Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

The Clinical Spectrum of Non-Traumatic Myelopathies in Childhood: 10 Years’ experience at a specialized center
Multiple Sclerosis
P11 - Poster Session 11 (8:00 AM-9:00 AM)
9-002

To describe the clinical features and outcomes of different etiologic subgroups of non-traumatic myelopathies that affect children.

The myelopathy spectrum and outcomes in children is very broad, characterization and comparison among etiologies may impact clinical approach.

Children with a diagnosis of myelopathy and age of onset less than 21 years of age seen at the Johns Hopkins Myelitis and Myelopathy Center (JHMMC) between January 2010 and June 2019 were included. Clinical profile, neurological examination, neuroimaging and cerebrospinal fluid (CSF) features were analyzed. Etiological subgroups included: autoimmune (AM), acute flaccid myelitis (AFM), non-AFM infection-related, vascular myelopathies (VM) and “other” etiologies. Functional disability defined by the modified Rankin score (mRs) was compared between etiologic subgroups at acute and convalescent phase of illness. Factors associated with worse disability were identified with multivariate logistic regression model

One-hunderd and thirty-one subjects were identified (mean age 9.5 years), of whom 50.4% were male. Thirty-four subjects were diagnosed with VM, 29 with AM, 18 with non-AFM infectious-related myelopathies, 40 with AFM and 10 with “other” etiologies. The mRs during the acute phase of illness was higher in the VM group (median 5) in comparison to the other etiology subgroups. All the groups improved from acute to convalescent stage of illness. However, during the convalescent stage, the VM and AFM groups had worse disability outcomes compared to AM, Non- AFM infection related and “other” etiologies. Respiratory failure was associated with worse mRs at convalescent stage (OR 2.41, p value 0.005).

In this large single center study, patients with VM and AFM etiology had worse functionality during both acute and convalescent phases of illness when compared to other etiology subgroups. All etiology groups showed improvement in disability scores from acute to convalescent phase. Factor associated with worse outcome included respiratory failure.

Authors/Disclosures
Maria A. Garcia-Dominguez, MD (UMass Memorial Medical Center)
PRESENTER
Dr. Garcia-Dominguez has received personal compensation for serving as an employee of Genentech.
Eliza M. Gordon-Lipkin, MD (Kennedy Krieger Institute) No disclosure on file
Laura S. Munoz-Arcos, MD (Johns Hopkins Hospital) No disclosure on file
No disclosure on file
Olwen Murphy, MD (Johns Hopkins Hospital) Dr. Murphy has nothing to disclose.
Carlos A. Pardo-Villamizar, MD (Johns Hopkins U, Med Dept of Neurology) The institution of Dr. Pardo-Villamizar has received research support from National Institutes of Health. The institution of Dr. Pardo-Villamizar has received research support from Bart McLean Fund for Neuroimmunology Research .